Evidence map›Paper›PMID 37309046›Full record

ArticleJournal of Zhejiang University. Science. B2023

Transportation of citrinin is regulated by the

Yanling Gui, Guangfu Tang, Haiqiao Man, Jiao Wang, Jie Han, Jiehong Zhao

Open access · greenAbstract read
In one paragraph

Article in Journal of Zhejiang University. Science. B, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Co-Culture ofJournal of fungi (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yanling GuiKey Lab of Pharmacognostics of Guizhou Province, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China.
Guangfu TangCollege of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China.
Haiqiao ManCollege of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China.
Jiao WangCollege of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China.
Jie HanKey Lab of Pharmacognostics of Guizhou Province, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China. hanjie202306@126.com.
Jiehong ZhaoKey Lab of Pharmacognostics of Guizhou Province, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China. zhaojiehong@126.com.
Guiyang College of Traditional Chinese Medicine · CN

Funding

the National Natural Science Foundation of China 81960692the Science and Technology Planning Project of Guizhou Province 2019-2776
6 · The paper itself

Abstract

Monascus is one of the most essential microbial resources in China, with thousands of years of history. Modern science has proved that Monascus can produce pigment, ergosterol, monacolin K, γ-aminobutyric acid, and other functionally active substances. Currently, Monascus is used to produce a variety of foods, health products, and pharmaceuticals, and its pigments are widely used as food additives. However, Monascus also makes a harmful polyketide component called citrinin in the fermentation process; citrinin has toxic effects on the kidneys such as teratogenicity, carcinogenicity, and mutagenicity (Gong et al., 2019). The presence of citrinin renders Monascus and its products potentially hazardous, which has led many countries to set limits and standards on citrinin content. For example, the citrinin limit is less than 0.04 mg/kg according to the Chinese document National Standard for Food Safety Food Additive Monascus (GB 1886.181-2016) (National Health and Family Planning Commission of the People's Republic of China, 2016), and the maximum level in food supplements based on rice fermented with Monascus purpureus is 100 µg/kg in the European Union (Commission of the European Union, 2019).

Indexed as

CitrininMonascusDietary SupplementsFungiCitrinin

Identifiers

PMID37309046
PMCPMC10264172
OpenAlexW4380422126

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.